September 22, 2008 - Philips displays its breadth of oncology care solutions at ASTRO 2008, showing three systems for oncology imaging – MR, CT and PET/CT – for tumor diagnosis and staging, therapy planning and therapy response monitoring.

September 22, 2008 – GE Healthcare launched its new Signa Magnetic Resonance Imaging (MRI) Oncology Package at ASTRO 2008.

The Signa MRI Oncology Package, a dedicated oncology solution, enhances magnetic resonance imaging for radiation therapy planning and is compatible with the most widely used GE MRI systems. The package consists of a detachable flat-surface patient table with indexed edges, flexible surface coils for high resolution imaging and treatment positioning aids.

September 22, 2008 - Calypso Medical Technologies Inc. today revealed the initiation of its latest clinical study, the PROBE clinical study (Prostatic Bed Experience with the Calypso 4D Localization System) to guide delivery of intensity modulated radiation therapy (IMRT) in prostate cancer patients following radical prostatectomy.

September 22, 2008 – GE Healthcare said the FDA cleared AdreView (Iobenguane I 123 Injection), a molecular imaging agent for the detection of rare neuroendocrine tumors in children and adults.

AdreView reportedly provides high quality images that allow physicians to detect tumors, both at the time of initial diagnosis and at later examinations when relapse or recurrence is suspected.

September 22, 2008 - A new study of breast cancer radiation treatment performed at 21st Century Oncology has found that Cianna Medical's SAVI applicator delivered excellent cosmetic results with minimal side effects, for women who had not qualified for breast conservation therapy using a previously available balloon device, according to the study.

September 22, 2008 - GE Healthcare demonstrated a new diagnostic tool for heart failure called SyncTool by Syntermed on its GE Xeleris 2 workstations at the American Society of Nuclear Cardiology, Sept. 10-14, in Boston.

Siemens has two new treatment planning approaches, IM-RealART Solution and IM-Confident Plan.

September 18, 2008 - ENTrigue Surgical Inc. announced the commercial release of its initial SerpENT Articulating Instruments for ENT surgery that utilize a patented technology that enables instruments to bend around corners, reportedly resulting in less invasive and more efficient surgical procedures.

The company also plans to commercialize several additional unique solutions for ENT procedures, including products based on absorbable polymer technologies.

September 18, 2008 – The Medical Imaging & Technology Alliance (MITA) said today that the results of the National CT Colonography Trial, published in this week’s New England Journal of Medicine, demonstrate the vast benefits of virtual colonoscopy (VC) as an important tool for colon cancer screening.

September 18, 2008 - CT colonographic screening identified 90 percent of subjects with adenomas or cancers measuring 10 mm or more in diameter, in a study of asymptomatic adults entitled “Accuracy of CT Colonography for Detection of Large Adenomas and Cancers,” led by C. Daniel Johnson, M.D., of the Mayo Clinic.

These findings augment published data on the role of CT colonography in screening patients with an average risk of colorectal cancer. (ClinicalTrials.gov number, NCT00084929 [ClinicalTrials.gov] ; American College of Radiology Imaging Network [ACRIN] number, 6664.)

Subscribe Now